Other Events ·
Jasper Therapeutics offers to buy back outstanding warrants for $0.324 each
JSPRJasper Therapeutics, Inc.
Jasper Therapeutics has commenced a tender offer to purchase all outstanding warrants at $0.324 in cash per warrant, without interest. As of October 6, 2026, there were 12,345,707 warrants outstanding, representing potential dilution if exercised at the $2.92 strike price. The company expects to pay approximately $4.0 million from cash on hand if all warrants are tendered. The offer is open until November 6, 2026, and is not conditioned on a minimum number of tenders. Warrants retired in this transaction will be cancelled. Jasper Therapeutics operates as a clinical-stage biotechnology company focused on developing innovative therapies for immune-mediated diseases.